Rifampin Injection Shortage Update: Current Availability and Manufacturer Information
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Rifampin Injection, an anti-infective medication, remains on the FDA drug shortage list. While the status is current, major manufacturers report that supplies are presently available.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Rifampin.
What's in Shortage
Rifampin Injection (Brand Name: RIFAMPIN) is currently listed in a shortage status by the FDA. This medication is classified as an anti-infective and is provided in an injection dosage form (600 mg).
Which Manufacturers Are Affected
The following manufacturers are currently listed in the FDA database regarding the supply of Rifampin Injection:
Mylan Institutional, a Viatris Company
- Status: Available
- Presentation: Rifampin, Injection, 600 mg/10 mL (NDC 67457-445-60)
- Contact: 800-796-9526
Fresenius Kabi USA, LLC
- Status: Available
- Presentation: Rifampin, Injection, 600 mg (NDC 63323-351-20)
- Note: The manufacturer suggests checking with wholesalers for current inventory.
- Contact: 888-386-1300
Why There's a Shortage
The FDA source data does not provide a specific reason for the current shortage status of Rifampin Injection.
What Patients Should Do
If you or a loved one are prescribed Rifampin Injection, please consider the following practical steps:
- Consult Your Healthcare Provider: Always discuss your treatment plan and any concerns regarding medication availability with your doctor.
- Speak with a Pharmacist: Clinical or hospital pharmacists can provide the most up-to-date information regarding their specific facility's inventory.
- Contact Manufacturers: You may use the contact numbers provided above to inquire about supply distribution and availability in your area.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider or pharmacist regarding medical treatments and alternatives.
Source
Information provided by the FDA Drug Shortage Database.
- Initial Posting Date: 02/17/2021
- Last Updated: 02/05/2026
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.